Is Cord Tissue Banking Worth It?

Is Cord Tissue Banking Worth It? New Cord Tissue Research, Aggressive Product Development and Lower Prices Make Cord Tissue Banking More Appealing NEW YORK, Feb. 3, 2014 - When Americord validated its proprietary method for harvesting and preserving... More

Is Cord Tissue Banking Worth It? New Cord Tissue Research, Aggressive Product Development and Lower Prices Make Cord Tissue Banking More Appealing NEW YORK, Feb. 3, 2014 - When Americord validated its proprietary method for harvesting and preserving mesenchymal stem cells (MSCs) from placenta tissue late last year, it joined leaders in the global scientific community who are increasingly investing significant resources in what many researchers believe represents the future of stem cell-based medical therapies. Found in vast quantities in both cord and placenta tissue, MSCs have unique properties that scientists believe may make them invaluable in the treatment of numerous diseases and regenerative therapies. Management believes Americord is the first cord blood banking company to harvest and store MSCs from both cord tissue and placenta tissue in the United States, and is the first to bring to market a way to collect and store MSCs from placenta tissue. MSCs are widely considered to be Less